Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?

Leukemia & lymphoma - 1 Apr 2008

Hartmann Elena M, Rosenwald Andreas

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Frequency
Share to Gene Rearrangement
Share to Immunoglobulin Heavy Chains
Share to Leukemia, Lymphocytic, Chronic, B-Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 18398727
DOI: 10.1080/10428190801959059

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic lymphocytic leukemia with mutated IgVH1-69 usage: a distinct CLL subgroup with more indolent behavior?PMID 18398727Read ↗

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatmentSemantic proximity Read ↗

IgVH mutations in patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia.Semantic proximity Read ↗

SnapShot: Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV geneSemantic proximity Read ↗

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic StrategiesSemantic proximity Read ↗

Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.Semantic proximity Read ↗

Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemiaSemantic proximity Read ↗

Molecular pathogenesis of chronic lymphocytic leukemia.Semantic proximity Read ↗

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical OutcomesSemantic proximity Read ↗

Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategiesSemantic proximity Read ↗

Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.